Great post P&P...check out the news on PKTX....
Chairman of ProtoKinetix Business Advisory Board Outlines Priorities
7:00a ET February 29, 2008 (Business Wire)
In response to a mandate from the board of directors and senior management of ProtoKinetix, Inc. (OTCBB: PKTX), Edward D. Martin, M.D., Chairman of its Business Advisory Board, has outlined his priorities and strategy for business development. "Our number one priority is to engage a big Health Care partner to advance our cell technology and to maximize the many commercial applications that exist," Dr. Martin commented. "We are involved in active dialogue with prospective partners and are confident that our discussions will result in meaningful partnerships," Martin said.
Referring to the announcement of Feb. 27, "Umbilical Cord Industry Tests ProtoKinetix' AAGP," Dr. Martin commented, "We have had our AAGP tested by universities, institutions and by ourselves; for the first time we have successfully completed testing with a commercial leader in cord blood research and the results are significant." Martin continued, "I am also pleased to report that another major Health Care corporation has invested in and is now completing exhaustive testing of our AAGP cryopreservation technology."
ProtoKinetix President & CEO Ross Senior remarked, "Bringing on an individual of the stature of Dr. Martin greatly aids our efforts to involve major Health Care companies in the development of our cell technology and to form strategic partnerships to advance the commercialization of our AAGP."
Mr. Senior also pointed out that currently there are a vast number of stem cells lost in the process of cultivation, storage, transportation and recovery from cryopreservation and that repeated tests have confirmed that the addition of AAGP(TM) to the cryopreservation process more than doubles the useable inventory of these very delicate and valuable cells. "This opens up multiple commercial opportunities in the multi-billion dollar stem cell frontier," Senior said, "we look forward to reporting progress in the days to come."
About Edward D. Martin, M.D.
Edward D. Martin, M.D., is the co-founder and Chairman of Martin, Blanck & Associates, Inc., a consulting firm to the health care industry, government, and to major health care information management and technology companies since March of 1998.
From July, 2000 through December, 2004, Dr. Martin was a Senior Vice President and the Chief Medical Officer at Science Applications International Corporation (SAIC) and continues to support SAIC on a part-time basis.
Dr. Martin had a distinguished 30-year career in public service as a commissioned officer in the United States Public Health Service, Department of Health and Human Services (formerly Department of Health, Education and Welfare). His last assignments were at the Department of Defense (DoD), where he served as the Acting Assistant Secretary of Defense (Health Affairs), and, prior to this appointment, as Principal Deputy Assistant Secretary of Defense (Health Affairs).
Dr. Martin arrived at the Pentagon in 1989 after 15 years of executive leadership positions with the Public Health Service (PHS). He served as Chief of Staff for C. Everett Koop, M.D., Surgeon General; Director, Bureau of Health Care Delivery and Assistance; Acting Deputy Administrator, Health Resources and Services Administration; and Director, Bureau of Community Health Services. Dr. Martin was commissioned in the PHS in May 1975 and held the rank of Rear Admiral upon his retirement in April 1998.
About ProtoKinetix
ProtoKinetix, Inc. is a biotechnology company that has developed and patented a family of synthetic anti-aging glycoproteins (AAGP(TM)) for medicine and the biotechnology and cosmetic industries. PKTX is currently in dialogue with major corporations and institutions who have contacted the company about the broad range of applications for AAGP(TM) products.
For more detailed information, please visit our website at: www.protokinetix.com
The Private Securities Litigation Reform Act of 1995 provides a "safe harbor" for forward-looking statements. Some information included in this press release contains statements that are forward looking. Such forward-looking information involves significant risks and uncertainties that could affect anticipated results in the future and, accordingly, these results may differ materially from those expressed in any forward-looking statements made by or on behalf of the Company. For a description of additional risks and uncertainties, please refer to the Company's filings with the Securities and Exchange Commission.
Mr. Ross L. Senior, LLB - President and CEO Company Office: Suite #1500 885 West Georgia Street Vancouver, BC V6C 3E8
SOURCE: ProtoKinetix, Inc.
ProtoKinetix, Inc. Blair Henderson, 604-687-9887
AI
Market Data 
Markets 
